Exclusive: Mercor’s Fast Growth Relies on Biggest AI Companies, Documents Show Save 25% to unlock this story

Sign in
Subscribe

    Data Tools

    • About Pro
    • Enterprise Software Startup Takeover List 2026
    • The Next GPs 2026
    • The Executives Leading the Data Center Race
    • The Next GPs 2025
    • The Rising Stars of AI Research
    • Leaders of the AI Shopping Revolution
    • Enterprise Software Startup Takeover List 2025
    • Org Charts
    • The Information 50 2025
    • Generative AI Takeover List
    • Generative AI Database
    • AI Chip Database
    • AI Data Center Database
    • Tech IPO Tracker
    • Tech Sentiment Tracker
    • Gigafactory Database

    Special Projects

    • The Information 50 Database
    • VC Diversity Index
    • Enterprise Tech Powerlist
  • Org Charts
  • Deep Research
  • Tech
  • Finance
  • Weekend
  • Charts
  • Events
  • TITV
    • Directory

      Search, find and engage with others who are serious about tech and business.

    • Forum

      Follow and be a part of discussions about tech, finance and media.

    • Brand Partnerships

      Premium advertising opportunities for brands

    • Group Subscriptions

      Team access to our exclusive tech news

    • Newsletters

      Journalists who break and shape the news, in your inbox

    • Video

      Catch up on conversations with global leaders in tech, media and finance

    • Partner Content

      Explore our recent partner collaborations

      XFacebookLinkedInThreadsInstagram
    • Help & Support
    • RSS Feed
    • Careers
    Sign in
  • About Pro
  • Enterprise Software Startup Takeover List 2026
  • The Next GPs 2026
  • The Executives Leading the Data Center Race
  • The Next GPs 2025
  • The Rising Stars of AI Research
  • Leaders of the AI Shopping Revolution
  • Enterprise Software Startup Takeover List 2025
  • Org Charts
  • The Information 50 2025
  • Generative AI Takeover List
  • Generative AI Database
  • AI Chip Database
  • AI Data Center Database
  • Tech IPO Tracker
  • Tech Sentiment Tracker
  • Gigafactory Database

SPECIAL PROJECTS

  • The Information 50 Database
  • VC Diversity Index
  • Enterprise Tech Powerlist
Deep Research
TITV
Tech
Finance
Weekend
Charts
Events
Newsletters
  • Directory

    Search, find and engage with others who are serious about tech and business.

  • Forum

    Follow and be a part of discussions about tech, finance and media.

  • Brand Partnerships

    Premium advertising opportunities for brands

  • Group Subscriptions

    Team access to our exclusive tech news

  • Newsletters

    Journalists who break and shape the news, in your inbox

  • Video

    Catch up on conversations with global leaders in tech, media and finance

  • Partner Content

    Explore our recent partner collaborations

Subscribe
  • Sign in
  • Search
  • Opinion
  • Venture Capital
  • Artificial Intelligence
  • Startups
  • Market Research
    XFacebookLinkedInThreadsInstagram
  • Help & Support
  • RSS Feed
  • Careers

Scale confidently.Scale confidently.

Learn more
Featured Partner
PwC logo
Exclusive

Hinge Health Valued at $3 Billion by Tiger Global, Coatue

Hinge Health co-founders Daniel Perez (left) and Gabriel Mecklenburg. Photo courtesy of Hinge Health
By
Kate Clark
[email protected]Profile and archive

Hinge Health, which sells virtual physical therapy sessions for customers with back and joint pain, has raised a financing round led jointly by Coatue Management and Tiger Global Management at a valuation of $3 billion, or seven times its last financing in April, according to two people familiar with the matter.

The San Francisco–based company has seen an influx of new customers during the pandemic as Americans develop musculoskeletal problems while working in makeshift home offices or seek to treat chronic conditions without in-person visits. The financing round illustrates how startups benefiting from the pandemic have been able to secure funding at steep valuations, in part due to record levels of dry powder at investment firms. The Series D round also reflects deepening interest in health-tech startups by hedge funds and growth equity funds, which typically invest in public or older private companies.

Recommended